Owlet (OWLT) Shares Outstanding (2020 - 2026)
Owlet's (OWLT) quarterly Shares Outstanding (Entity) came in at $28.1 million in Q1 2026, up 77.74% year-on-year from $15.8 million in Q1 2025, and up 55.3% on a QoQ basis from $18.1 million in Q4 2025.
Owlet (OWLT) Shares Outstanding (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Shares Outstanding (Entity) data on file, last reported at $28.1 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 77.74% year-over-year to $28.1 million in Q1 2026; TTM through Mar 2026 was $28.1 million, a 77.74% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, up 65.22% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $28.1 million, up from $18.1 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for OWLT reached as high as $28.1 million in Q1 2026 and fell as low as $8.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $11.9 million across 5 years, with a median of $9.0 million in 2024.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 410.06% in 2022 and fell as far as 1.8% in 2022.
- Year by year, Shares Outstanding (Entity) stood at $8.2 million in 2022, then advanced by 6.74% to $8.8 million in 2023, then advanced by 24.48% to $11.0 million in 2024, then surged by 65.22% to $18.1 million in 2025, then jumped by 55.3% to $28.1 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $28.1 million in Q1 2026, $18.1 million in Q4 2025, and $16.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn | 27.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.42 Mn |
| Dec 31, 2025 | 18.09 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Jun 30, 2025 | 15.72 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 10.95 Mn |
| Sep 30, 2024 | 11.04 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Mar 31, 2024 | 8.74 Mn |
| Dec 31, 2023 | 8.28 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 8.21 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 7.95 Mn |
| Sep 30, 2022 | 7.98 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 6.91 Mn |
| Jun 30, 2021 | 1.61 Mn |